Ampio Pharmaceuticals Statistics
Share Statistics
Ampio Pharmaceuticals has 1.14M shares outstanding. The number of shares has increased by 36.46% in one year.
| Shares Outstanding | 1.14M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.12M |
| Failed to Deliver (FTD) Shares | 2 |
| FTD / Avg. Volume | 0.17% |
Short Selling Information
The latest short interest is 32.90K, so 2.9% of the outstanding shares have been sold short.
| Short Interest | 32.90K |
| Short % of Shares Out | 2.9% |
| Short % of Float | 2.94% |
| Short Ratio (days to cover) | 0.31 |
Valuation Ratios
The PE ratio is -0.19 and the forward PE ratio is -0.01.
| PE Ratio | -0.19 |
| Forward PE | -0.01 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 0.49 |
| P/FCF Ratio | -0.19 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Ampio Pharmaceuticals Inc..
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.41 |
| Quick Ratio | 2.41 |
| Debt / Equity | 0.08 |
| Total Debt / Capitalization | 7.54 |
| Cash Flow / Debt | -31.26 |
| Interest Coverage | 0 |
Financial Efficiency
Return on equity (ROE) is -2.57% and return on capital (ROIC) is -261.92%.
| Return on Equity (ROE) | -2.57% |
| Return on Assets (ROA) | -1.5% |
| Return on Capital (ROIC) | -261.92% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -1.44M |
| Employee Count | 6 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 3.71, so Ampio Pharmaceuticals 's price volatility has been higher than the market average.
| Beta | 3.71 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.12 |
| Relative Strength Index (RSI) | 42.9 |
| Average Volume (20 Days) | 1.17K |
Income Statement
| Revenue | n/a |
| Gross Profit | -250.00K |
| Operating Income | -9.52M |
| Net Income | -8.63M |
| EBITDA | 0 |
| EBIT | n/a |
| Earnings Per Share (EPS) | -10.67 |
Balance Sheet
The company has 4.09M in cash and 274.00K in debt, giving a net cash position of 3.81M.
| Cash & Cash Equivalents | 4.09M |
| Total Debt | 274.00K |
| Net Cash | 3.81M |
| Retained Earnings | -242.53M |
| Total Assets | 5.74M |
| Working Capital | 3.36M |
Cash Flow
In the last 12 months, operating cash flow was -8.56M and capital expenditures 0, giving a free cash flow of -8.56M.
| Operating Cash Flow | -8.56M |
| Capital Expenditures | 0 |
| Free Cash Flow | -8.56M |
| FCF Per Share | -10.59 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AMPE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | -290108.4% |
Analyst Forecast
Currently there are no analyst rating for AMPE.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Sep 12, 2023. It was a backward split with a ratio of 1:20.
| Last Split Date | Sep 12, 2023 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -63.72 |
| Piotroski F-Score | 2 |